收费全文 | 4232篇 |
免费 | 163篇 |
国内免费 | 39篇 |
耳鼻咽喉 | 19篇 |
儿科学 | 119篇 |
妇产科学 | 89篇 |
基础医学 | 495篇 |
口腔科学 | 79篇 |
临床医学 | 281篇 |
内科学 | 1091篇 |
皮肤病学 | 82篇 |
神经病学 | 413篇 |
特种医学 | 145篇 |
外科学 | 681篇 |
综合类 | 22篇 |
预防医学 | 222篇 |
眼科学 | 93篇 |
药学 | 245篇 |
中国医学 | 25篇 |
肿瘤学 | 333篇 |
2023年 | 30篇 |
2022年 | 71篇 |
2021年 | 122篇 |
2020年 | 69篇 |
2019年 | 91篇 |
2018年 | 137篇 |
2017年 | 79篇 |
2016年 | 98篇 |
2015年 | 126篇 |
2014年 | 173篇 |
2013年 | 252篇 |
2012年 | 304篇 |
2011年 | 329篇 |
2010年 | 202篇 |
2009年 | 160篇 |
2008年 | 306篇 |
2007年 | 272篇 |
2006年 | 250篇 |
2005年 | 269篇 |
2004年 | 229篇 |
2003年 | 204篇 |
2002年 | 196篇 |
2001年 | 31篇 |
2000年 | 29篇 |
1999年 | 17篇 |
1998年 | 39篇 |
1997年 | 28篇 |
1996年 | 29篇 |
1995年 | 21篇 |
1994年 | 20篇 |
1993年 | 21篇 |
1992年 | 17篇 |
1991年 | 16篇 |
1990年 | 12篇 |
1989年 | 11篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 9篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1982年 | 10篇 |
1980年 | 10篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1973年 | 8篇 |
1972年 | 7篇 |
1971年 | 11篇 |
1969年 | 5篇 |
1968年 | 7篇 |
1967年 | 6篇 |
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) leads to prolonged survival for selected patients with colorectal (CRC) peritoneal metastases (PM). This study aimed to analyze the prognostic role of micro-satellite (MS) status and RAS/RAF mutations for patients treated with CRS.
MethodsData were collected from 13 Italian centers with PM expertise within a collaborative group of the Italian Society of Surgical Oncology. Clinical and pathologic variables and KRAS/NRAS/BRAF mutational and MS status were correlated with overall survival (OS) and disease-free survival (DFS).
ResultsThe study enrolled 437 patients treated with CRS-HIPEC. The median OS was 42.3 months [95% confidence interval (CI), 33.4–51.2 months], and the median DFS was 13.6 months (95% CI, 12.3–14.9 months). The local (peritoneal) DFS was 20.5 months (95% CI, 16.4–24.6 months). In addition to the known clinical factors, KRAS mutations (p = 0.005), BRAF mutations (p = 0.01), and MS status (p = 0.04) were related to survival. The KRAS- and BRAF-mutated patients had a shorter survival than the wild-type (WT) patients (5-year OS, 29.4% and 26.8% vs 51.5%, respectively). The patients with micro-satellite instability (MSI) had a longer survival than the patients with micro-satellite stability (MSS) (5-year OS, 58.3% vs 36.7%). The MSI/WT patients had the best prognosis. The MSS/WT and MSI/mutated patients had similar survivals, whereas the MSS/mutated patients showed the worst prognosis (5-year OS, 70.6%, 48.1%, 23.4%; p = 0.0001). In the multivariable analysis, OS was related to the Peritoneal Cancer Index [hazard ratio (HR), 1.05 per point], completeness of cytoreduction (CC) score (HR, 2.8), N status (HR, 1.6), signet-ring (HR, 2.4), MSI/WT (HR, 0.5), and MSS/WT-MSI/mutation (HR, 0.4). Similar results were obtained for DFS.
ConclusionFor patients affected by CRC-PM who are eligible for CRS, clinical and pathologic criteria need to be integrated with molecular features (KRAS/BRAF mutation). Micro-satellite status should be strongly considered because MSI confers a survival advantage over MSS, even for mutated patients.
相似文献Malignant intraventricular meningiomas (IVMs) are very rare with only a few reported cases. A midline search up to December 2020 selected 40 articles for a total of 65 patients. The inclusion criteria were series and case reports in English language, as well as papers written in other languages, but with abstracts written in English. Malignant IVMs at the first diagnosis (group A, 50 patients) and those with anaplastic transformation from previous WHO grades I and II tumors (group B, 15 patients) were separately analyzed. The unique personal case among 1285 meningiomas (0.078%) is also added. Malignant IVMs mainly occur in women (61%) with a median age of 45 years and are mainly located in the lateral ventricle (93%) and trigonal region (74%), with no cases in the fourth ventricle. Irregular borders (80%), heterogeneous enhancement (83%), and perilesional edema (76%) are the most frequent radiological findings. The histology was mainly pure anaplastic (85%), whereas papillary (7%), rhabdoid (5%), and mixed forms (3%) are very rare. The CSF spread was found in 60% of the cases. The prognosis is very dismal, with an overall median survival of 17.5 months after surgery for the anaplastic forms. Malignant IVMs at initial diagnosis (group A) show better overall survival (25 months) than those occurring from anaplastic transformation of lower grade tumors (group B) (10.1 months).
相似文献